Loading…

Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases

Background and purposeCerebral large artery and small vessel diseases are related to different pathogenetic mechanisms and have different risk factor profile. Lipoprotein(a) (Lp(a)) was shown to promote atherosclerosis but data was limited on its association with cerebral small vessel diseases (cSVD...

Full description

Saved in:
Bibliographic Details
Published in:Stroke and vascular neurology 2022-07, Vol.7 (6), p.534-540
Main Authors: Pan, Yuesong, Cai, Xueli, Jing, Jing, Wang, Suying, Meng, Xia, Mei, Lerong, Yang, Yingying, Jin, Aoming, DongXiao, Yao, Li, Shan, Li, Hao, Wei, Tiemin, Wang, Yongjun, Wang, Yilong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b551t-8e783491729a652cff0ad39a68f038ce98068d258145a30d38a308c2964604ca3
cites cdi_FETCH-LOGICAL-b551t-8e783491729a652cff0ad39a68f038ce98068d258145a30d38a308c2964604ca3
container_end_page 540
container_issue 6
container_start_page 534
container_title Stroke and vascular neurology
container_volume 7
creator Pan, Yuesong
Cai, Xueli
Jing, Jing
Wang, Suying
Meng, Xia
Mei, Lerong
Yang, Yingying
Jin, Aoming
DongXiao, Yao
Li, Shan
Li, Hao
Wei, Tiemin
Wang, Yongjun
Wang, Yilong
description Background and purposeCerebral large artery and small vessel diseases are related to different pathogenetic mechanisms and have different risk factor profile. Lipoprotein(a) (Lp(a)) was shown to promote atherosclerosis but data was limited on its association with cerebral small vessel diseases (cSVD). The objective of this study was to assess the associations of Lp(a) level with the two types of cerebrovascular diseases.MethodsCommunity-dwelling subjects aged 50–75 years from the baseline survey of The PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events study were included. Lp(a) concentrations was measured and categorised into three groups according to the tertiles. Eligible participants were scanned by a 3.0T MRI scanner and assessed for intracranial atherosclerosis and cSVD burden based on four imaging markers.ResultsThis study included 3059 subjects. The average age of the participants was 61.2±6.7 years, and 53.5% (1636) were female. Compared with the first tertile, subjects with the second and third tertiles of Lp(a) concentrations were associated with an increased odds of presence of intracranial plaque (18.7% vs 15.4%, adj.OR 1.37, 95% CI 1.08 to 1.75; 18.9% vs 15.4%, adj.OR 1.34, 95% CI 1.05 to 1.72). Similar associations were observed for intracranial atherosclerotic burden. Whereas, subjects with the third tertile of Lp(a) level had a decreased odds of presence of cSVD (25.9% vs 31.7%, adj.OR 0.74, 95% CI 0.60 to 0.92) and lower cSVD burden (adj.cOR 0.76, 95% CI 0.62 to 0.94).ConclusionsIn this study, Lp(a) concentrations were positively associated with presence and burden of intracranial atherosclerosis, but was inversely associated with cSVD.Trial registration number NCT03178448.
doi_str_mv 10.1136/svn-2022-001625
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_06d9e12e4a61448ca28b27fb89fc16bb</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_06d9e12e4a61448ca28b27fb89fc16bb</doaj_id><sourcerecordid>2691787524</sourcerecordid><originalsourceid>FETCH-LOGICAL-b551t-8e783491729a652cff0ad39a68f038ce98068d258145a30d38a308c2964604ca3</originalsourceid><addsrcrecordid>eNp9ks9rFDEUxwdRbKk9e5MBLxUZm9_zchFK_VUoeNFzyGRetlmykzWZXel_b-rU1Qp6ScLM532S9_g2zXNK3lDK1XnZTx0jjHWEUMXko-aYEak7UFo9PpwBjprTUtakQtD3muinzRGXICmn6rjx74L3mHGag42tLSW5YOeQptIm38awTducZgzTmX3VRtxjbL-H-aZ1tWbItSTavMLW5hnzbWunsS0bG2O7x1IqO4aCtmB51jzxNhY8vd9Pmq8f3n-5_NRdf_54dXlx3Q1S0rkD7IELTXumrZLMeU_syOsZPOHgUANRMDIJVEjLycihruCYVkIR4Sw_aa4W75js2mxz2Nh8a5IN5ueHlFemPjW4iIaoUSNlKKyiQoCzDAbW-wG0d1QNQ3W9XVzb3bDB0dUZ1YYfSB_-mcKNWaW90UCp1H0VnN0Lcvq2wzKbTSgOY7QTpl0xTNVOoZdMVPTlX-g67fJUR2VYL5WoAxH0v1R1SaoBeKXOF8rlVEpGf3gyJeYuOKYGx9wFxyzBqRUv_uz0wP-KSQVeL8CwWf--81-6H5Z7y4Q</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2691519883</pqid></control><display><type>article</type><title>Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases</title><source>BMJ Open Access Journals</source><source>PubMed Central</source><creator>Pan, Yuesong ; Cai, Xueli ; Jing, Jing ; Wang, Suying ; Meng, Xia ; Mei, Lerong ; Yang, Yingying ; Jin, Aoming ; DongXiao, Yao ; Li, Shan ; Li, Hao ; Wei, Tiemin ; Wang, Yongjun ; Wang, Yilong</creator><creatorcontrib>Pan, Yuesong ; Cai, Xueli ; Jing, Jing ; Wang, Suying ; Meng, Xia ; Mei, Lerong ; Yang, Yingying ; Jin, Aoming ; DongXiao, Yao ; Li, Shan ; Li, Hao ; Wei, Tiemin ; Wang, Yongjun ; Wang, Yilong</creatorcontrib><description>Background and purposeCerebral large artery and small vessel diseases are related to different pathogenetic mechanisms and have different risk factor profile. Lipoprotein(a) (Lp(a)) was shown to promote atherosclerosis but data was limited on its association with cerebral small vessel diseases (cSVD). The objective of this study was to assess the associations of Lp(a) level with the two types of cerebrovascular diseases.MethodsCommunity-dwelling subjects aged 50–75 years from the baseline survey of The PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events study were included. Lp(a) concentrations was measured and categorised into three groups according to the tertiles. Eligible participants were scanned by a 3.0T MRI scanner and assessed for intracranial atherosclerosis and cSVD burden based on four imaging markers.ResultsThis study included 3059 subjects. The average age of the participants was 61.2±6.7 years, and 53.5% (1636) were female. Compared with the first tertile, subjects with the second and third tertiles of Lp(a) concentrations were associated with an increased odds of presence of intracranial plaque (18.7% vs 15.4%, adj.OR 1.37, 95% CI 1.08 to 1.75; 18.9% vs 15.4%, adj.OR 1.34, 95% CI 1.05 to 1.72). Similar associations were observed for intracranial atherosclerotic burden. Whereas, subjects with the third tertile of Lp(a) level had a decreased odds of presence of cSVD (25.9% vs 31.7%, adj.OR 0.74, 95% CI 0.60 to 0.92) and lower cSVD burden (adj.cOR 0.76, 95% CI 0.62 to 0.94).ConclusionsIn this study, Lp(a) concentrations were positively associated with presence and burden of intracranial atherosclerosis, but was inversely associated with cSVD.Trial registration number NCT03178448.</description><identifier>ISSN: 2059-8688</identifier><identifier>EISSN: 2059-8696</identifier><identifier>DOI: 10.1136/svn-2022-001625</identifier><identifier>PMID: 35851316</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd</publisher><subject>Anticoagulants ; Antihypertensives ; Apolipoproteins ; Atherosclerosis ; Blood pressure ; Cerebrospinal fluid ; cerebrovascular disorders ; Cholesterol ; Cognitive ability ; Contraindications ; Data collection ; Diabetes ; Fasting ; Glucose ; Hypertension ; Investigations ; Lipoproteins ; Magnetic Resonance Imaging ; Medical imaging ; Neuroimaging ; Original Research ; plaque ; Regression analysis ; Reproducibility ; Veins &amp; arteries</subject><ispartof>Stroke and vascular neurology, 2022-07, Vol.7 (6), p.534-540</ispartof><rights>Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b551t-8e783491729a652cff0ad39a68f038ce98068d258145a30d38a308c2964604ca3</citedby><cites>FETCH-LOGICAL-b551t-8e783491729a652cff0ad39a68f038ce98068d258145a30d38a308c2964604ca3</cites><orcidid>0000-0001-9431-9925 ; 0000-0002-3220-2382 ; 0000-0002-8591-4105 ; 0000-0003-3082-6789</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://svn.bmj.com/content/7/6/534.full.pdf$$EPDF$$P50$$Gbmj$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://svn.bmj.com/content/7/6/534.full$$EHTML$$P50$$Gbmj$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793,55350,77660,77686</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35851316$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pan, Yuesong</creatorcontrib><creatorcontrib>Cai, Xueli</creatorcontrib><creatorcontrib>Jing, Jing</creatorcontrib><creatorcontrib>Wang, Suying</creatorcontrib><creatorcontrib>Meng, Xia</creatorcontrib><creatorcontrib>Mei, Lerong</creatorcontrib><creatorcontrib>Yang, Yingying</creatorcontrib><creatorcontrib>Jin, Aoming</creatorcontrib><creatorcontrib>DongXiao, Yao</creatorcontrib><creatorcontrib>Li, Shan</creatorcontrib><creatorcontrib>Li, Hao</creatorcontrib><creatorcontrib>Wei, Tiemin</creatorcontrib><creatorcontrib>Wang, Yongjun</creatorcontrib><creatorcontrib>Wang, Yilong</creatorcontrib><title>Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases</title><title>Stroke and vascular neurology</title><addtitle>Stroke Vasc Neurol</addtitle><addtitle>Stroke Vasc Neurol</addtitle><description>Background and purposeCerebral large artery and small vessel diseases are related to different pathogenetic mechanisms and have different risk factor profile. Lipoprotein(a) (Lp(a)) was shown to promote atherosclerosis but data was limited on its association with cerebral small vessel diseases (cSVD). The objective of this study was to assess the associations of Lp(a) level with the two types of cerebrovascular diseases.MethodsCommunity-dwelling subjects aged 50–75 years from the baseline survey of The PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events study were included. Lp(a) concentrations was measured and categorised into three groups according to the tertiles. Eligible participants were scanned by a 3.0T MRI scanner and assessed for intracranial atherosclerosis and cSVD burden based on four imaging markers.ResultsThis study included 3059 subjects. The average age of the participants was 61.2±6.7 years, and 53.5% (1636) were female. Compared with the first tertile, subjects with the second and third tertiles of Lp(a) concentrations were associated with an increased odds of presence of intracranial plaque (18.7% vs 15.4%, adj.OR 1.37, 95% CI 1.08 to 1.75; 18.9% vs 15.4%, adj.OR 1.34, 95% CI 1.05 to 1.72). Similar associations were observed for intracranial atherosclerotic burden. Whereas, subjects with the third tertile of Lp(a) level had a decreased odds of presence of cSVD (25.9% vs 31.7%, adj.OR 0.74, 95% CI 0.60 to 0.92) and lower cSVD burden (adj.cOR 0.76, 95% CI 0.62 to 0.94).ConclusionsIn this study, Lp(a) concentrations were positively associated with presence and burden of intracranial atherosclerosis, but was inversely associated with cSVD.Trial registration number NCT03178448.</description><subject>Anticoagulants</subject><subject>Antihypertensives</subject><subject>Apolipoproteins</subject><subject>Atherosclerosis</subject><subject>Blood pressure</subject><subject>Cerebrospinal fluid</subject><subject>cerebrovascular disorders</subject><subject>Cholesterol</subject><subject>Cognitive ability</subject><subject>Contraindications</subject><subject>Data collection</subject><subject>Diabetes</subject><subject>Fasting</subject><subject>Glucose</subject><subject>Hypertension</subject><subject>Investigations</subject><subject>Lipoproteins</subject><subject>Magnetic Resonance Imaging</subject><subject>Medical imaging</subject><subject>Neuroimaging</subject><subject>Original Research</subject><subject>plaque</subject><subject>Regression analysis</subject><subject>Reproducibility</subject><subject>Veins &amp; arteries</subject><issn>2059-8688</issn><issn>2059-8696</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>9YT</sourceid><sourceid>DOA</sourceid><recordid>eNp9ks9rFDEUxwdRbKk9e5MBLxUZm9_zchFK_VUoeNFzyGRetlmykzWZXel_b-rU1Qp6ScLM532S9_g2zXNK3lDK1XnZTx0jjHWEUMXko-aYEak7UFo9PpwBjprTUtakQtD3muinzRGXICmn6rjx74L3mHGag42tLSW5YOeQptIm38awTducZgzTmX3VRtxjbL-H-aZ1tWbItSTavMLW5hnzbWunsS0bG2O7x1IqO4aCtmB51jzxNhY8vd9Pmq8f3n-5_NRdf_54dXlx3Q1S0rkD7IELTXumrZLMeU_syOsZPOHgUANRMDIJVEjLycihruCYVkIR4Sw_aa4W75js2mxz2Nh8a5IN5ueHlFemPjW4iIaoUSNlKKyiQoCzDAbW-wG0d1QNQ3W9XVzb3bDB0dUZ1YYfSB_-mcKNWaW90UCp1H0VnN0Lcvq2wzKbTSgOY7QTpl0xTNVOoZdMVPTlX-g67fJUR2VYL5WoAxH0v1R1SaoBeKXOF8rlVEpGf3gyJeYuOKYGx9wFxyzBqRUv_uz0wP-KSQVeL8CwWf--81-6H5Z7y4Q</recordid><startdate>20220718</startdate><enddate>20220718</enddate><creator>Pan, Yuesong</creator><creator>Cai, Xueli</creator><creator>Jing, Jing</creator><creator>Wang, Suying</creator><creator>Meng, Xia</creator><creator>Mei, Lerong</creator><creator>Yang, Yingying</creator><creator>Jin, Aoming</creator><creator>DongXiao, Yao</creator><creator>Li, Shan</creator><creator>Li, Hao</creator><creator>Wei, Tiemin</creator><creator>Wang, Yongjun</creator><creator>Wang, Yilong</creator><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>9YT</scope><scope>ACMMV</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9431-9925</orcidid><orcidid>https://orcid.org/0000-0002-3220-2382</orcidid><orcidid>https://orcid.org/0000-0002-8591-4105</orcidid><orcidid>https://orcid.org/0000-0003-3082-6789</orcidid></search><sort><creationdate>20220718</creationdate><title>Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases</title><author>Pan, Yuesong ; Cai, Xueli ; Jing, Jing ; Wang, Suying ; Meng, Xia ; Mei, Lerong ; Yang, Yingying ; Jin, Aoming ; DongXiao, Yao ; Li, Shan ; Li, Hao ; Wei, Tiemin ; Wang, Yongjun ; Wang, Yilong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b551t-8e783491729a652cff0ad39a68f038ce98068d258145a30d38a308c2964604ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anticoagulants</topic><topic>Antihypertensives</topic><topic>Apolipoproteins</topic><topic>Atherosclerosis</topic><topic>Blood pressure</topic><topic>Cerebrospinal fluid</topic><topic>cerebrovascular disorders</topic><topic>Cholesterol</topic><topic>Cognitive ability</topic><topic>Contraindications</topic><topic>Data collection</topic><topic>Diabetes</topic><topic>Fasting</topic><topic>Glucose</topic><topic>Hypertension</topic><topic>Investigations</topic><topic>Lipoproteins</topic><topic>Magnetic Resonance Imaging</topic><topic>Medical imaging</topic><topic>Neuroimaging</topic><topic>Original Research</topic><topic>plaque</topic><topic>Regression analysis</topic><topic>Reproducibility</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pan, Yuesong</creatorcontrib><creatorcontrib>Cai, Xueli</creatorcontrib><creatorcontrib>Jing, Jing</creatorcontrib><creatorcontrib>Wang, Suying</creatorcontrib><creatorcontrib>Meng, Xia</creatorcontrib><creatorcontrib>Mei, Lerong</creatorcontrib><creatorcontrib>Yang, Yingying</creatorcontrib><creatorcontrib>Jin, Aoming</creatorcontrib><creatorcontrib>DongXiao, Yao</creatorcontrib><creatorcontrib>Li, Shan</creatorcontrib><creatorcontrib>Li, Hao</creatorcontrib><creatorcontrib>Wei, Tiemin</creatorcontrib><creatorcontrib>Wang, Yongjun</creatorcontrib><creatorcontrib>Wang, Yilong</creatorcontrib><collection>BMJ Open Access Journals</collection><collection>BMJ Journals:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Stroke and vascular neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pan, Yuesong</au><au>Cai, Xueli</au><au>Jing, Jing</au><au>Wang, Suying</au><au>Meng, Xia</au><au>Mei, Lerong</au><au>Yang, Yingying</au><au>Jin, Aoming</au><au>DongXiao, Yao</au><au>Li, Shan</au><au>Li, Hao</au><au>Wei, Tiemin</au><au>Wang, Yongjun</au><au>Wang, Yilong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases</atitle><jtitle>Stroke and vascular neurology</jtitle><stitle>Stroke Vasc Neurol</stitle><addtitle>Stroke Vasc Neurol</addtitle><date>2022-07-18</date><risdate>2022</risdate><volume>7</volume><issue>6</issue><spage>534</spage><epage>540</epage><pages>534-540</pages><issn>2059-8688</issn><eissn>2059-8696</eissn><abstract>Background and purposeCerebral large artery and small vessel diseases are related to different pathogenetic mechanisms and have different risk factor profile. Lipoprotein(a) (Lp(a)) was shown to promote atherosclerosis but data was limited on its association with cerebral small vessel diseases (cSVD). The objective of this study was to assess the associations of Lp(a) level with the two types of cerebrovascular diseases.MethodsCommunity-dwelling subjects aged 50–75 years from the baseline survey of The PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events study were included. Lp(a) concentrations was measured and categorised into three groups according to the tertiles. Eligible participants were scanned by a 3.0T MRI scanner and assessed for intracranial atherosclerosis and cSVD burden based on four imaging markers.ResultsThis study included 3059 subjects. The average age of the participants was 61.2±6.7 years, and 53.5% (1636) were female. Compared with the first tertile, subjects with the second and third tertiles of Lp(a) concentrations were associated with an increased odds of presence of intracranial plaque (18.7% vs 15.4%, adj.OR 1.37, 95% CI 1.08 to 1.75; 18.9% vs 15.4%, adj.OR 1.34, 95% CI 1.05 to 1.72). Similar associations were observed for intracranial atherosclerotic burden. Whereas, subjects with the third tertile of Lp(a) level had a decreased odds of presence of cSVD (25.9% vs 31.7%, adj.OR 0.74, 95% CI 0.60 to 0.92) and lower cSVD burden (adj.cOR 0.76, 95% CI 0.62 to 0.94).ConclusionsIn this study, Lp(a) concentrations were positively associated with presence and burden of intracranial atherosclerosis, but was inversely associated with cSVD.Trial registration number NCT03178448.</abstract><cop>England</cop><pub>BMJ Publishing Group Ltd</pub><pmid>35851316</pmid><doi>10.1136/svn-2022-001625</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-9431-9925</orcidid><orcidid>https://orcid.org/0000-0002-3220-2382</orcidid><orcidid>https://orcid.org/0000-0002-8591-4105</orcidid><orcidid>https://orcid.org/0000-0003-3082-6789</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2059-8688
ispartof Stroke and vascular neurology, 2022-07, Vol.7 (6), p.534-540
issn 2059-8688
2059-8696
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_06d9e12e4a61448ca28b27fb89fc16bb
source BMJ Open Access Journals; PubMed Central
subjects Anticoagulants
Antihypertensives
Apolipoproteins
Atherosclerosis
Blood pressure
Cerebrospinal fluid
cerebrovascular disorders
Cholesterol
Cognitive ability
Contraindications
Data collection
Diabetes
Fasting
Glucose
Hypertension
Investigations
Lipoproteins
Magnetic Resonance Imaging
Medical imaging
Neuroimaging
Original Research
plaque
Regression analysis
Reproducibility
Veins & arteries
title Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T11%3A12%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20associations%20of%20lipoprotein(a)%20level%20with%20cerebral%20large%20artery%20and%20small%20vessel%20diseases&rft.jtitle=Stroke%20and%20vascular%20neurology&rft.au=Pan,%20Yuesong&rft.date=2022-07-18&rft.volume=7&rft.issue=6&rft.spage=534&rft.epage=540&rft.pages=534-540&rft.issn=2059-8688&rft.eissn=2059-8696&rft_id=info:doi/10.1136/svn-2022-001625&rft_dat=%3Cproquest_doaj_%3E2691787524%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b551t-8e783491729a652cff0ad39a68f038ce98068d258145a30d38a308c2964604ca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2691519883&rft_id=info:pmid/35851316&rfr_iscdi=true